Ovarian cancer patient with germline mutations in both BRCA1 and NBN genes

Cancer Genetics and Cytogenetics

Volumn 186, Issue 2, 2008, Pages 122-124

  Porhanova, Nathalia V ^a   Sokolenko, Anna P ^b   Sherina, Nathalia Yu ^b   Ponomariova, Daria N ^b   Tkachenko, Nathalia N ^a   Matsko, Dmitry E ^b   Imyanitov, Evgeny N ^b  

^a Regional Oncological Hospital   (Russian Federation)

^b N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CARBOPLATIN; DNA; NIBRIN;

ADULT; ANAMNESIS; BLOOD SAMPLING; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER SUSCEPTIBILITY; CASE REPORT; CLINICAL FEATURE; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; GERM LINE; HETEROZYGOSITY; HUMAN; LETTER; MULTIPLE CYCLE TREATMENT; OVARY ADENOCARCINOMA; PRIORITY JOURNAL;

CELL CYCLE PROTEINS; FEMALE; GENES, BRCA1; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; NUCLEAR PROTEINS; OVARIAN NEOPLASMS;

EID: 53449083734     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.06.012     Document Type: Letter

References (21)

1. Eyfjord J.E., and Bodvarsdottir S.K. Genomic instability and cancer: networks involved in response to DNA damage. Mutat Res 592 (2005) 18-28
2. Oldenburg R.A., Meijers-Heijboer H., Cornelisse C.J., and Devilee P. Genetic susceptibility for breast cancer: how many more genes to be found?. Crit Rev Oncol Hematol 63 (2007) 125-149
3. The International Nijmegen Breakage Syndrome Study Group. Nijmegen breakage syndrome. Arch Dis Child 82 (2000) 400-406
4. Steffen J., Varon R., Mosor M., Maneva G., Maurer M., Stumm M., Nowakowska D., Rubach M., Kosakowska E., Ruka W., Nowecki Z., Rutkowski P., Demkow T., Sadowska M., Bidziński M., Gawrychowski K., and Sperling K. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int J Cancer 111 (2004) 67-71
5. Seemanová E., Jarolim P., Seeman P., Varon R., Digweed M., Swift M., and Sperling K. Cancer risk of heterozygotes with the NBN founder mutation. J Natl Cancer Inst 99 (2007) 1875-1880
6. Menkiszak J., Gronwald J., Górski B., Jakubowska A., Huzarski T., Byrski T., Foszczyńska-Kłoda M., Haus O., Janiszewska H., Perkowska M., Brozek I., Grzybowska E., Zientek H., Góźdź S., Kozak-Klonowska B., Urbański K., Miturski R., Kowalczyk J., Pluzańska A., Niepsuj S., Koc J., Szwiec M., Drosik K., Mackiewicz A., Lamperska K., Strózyk E., Godlewski D., Stawicka M., Waśko B., Bebenek M., Rozmiarek A., Rzepka-Górska I., Narod S.A., and Lubiński J. Hereditary ovarian cancer in Poland. Int J Cancer 106 (2003) 942-945
7. Górski B., Cybulski C., Huzarski T., Byrski T., Gronwald J., Jakubowska A., Stawicka M., Gozdecka-Grodecka S., Szwiec M., Urbański K., Mituś J., Marczyk E., Dziuba J., Wandzel P., Surdyka D., Haus O., Janiszewska H., Debniak T., Tołoczko-Grabarek A., Medrek K., Masojć B., Mierzejewski M., Kowalska E., Narod S.A., and Lubiński J. Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat 92 (2005) 19-24
8. Krylova N., Lobeiko O.S., Sokolenko A.P., Iyevleva A.G., Rozanov M.E., Mitiushkina N.V., Gergova M.M., Porhanova N.V., Urmancheyeva A.F., SYa M., Togo A.V., and Imyanitov E.N. BRCA1 4153delA founder mutation in Russian ovarian cancer patients. Hered Cancer Clin Pract 4 (2006) 193-196
9. Sokolenko A.P., Mitiushkina N.V., Buslov K.G., Bit-Sava E.M., Iyevleva A.G., Chekmariova E.V., Kuligina E., Ulibina Y.M., Rozanov M.E., Suspitsin E.N., Matsko D.E., Chagunava O.L., Trofimov D.Y., Devilee P., Cornelisse C., Togo A.V., Semiglazov V.F., and Imyanitov E.N. High frequency of BRCA1 5382insC mutation in Russian breast cancer patients. Eur J Cancer 42 (2006) 1380-1384
10. Górski B., Debniak T., Masojć B., Mierzejewski M., Medrek K., Cybulski C., Jakubowska A., Kurzawski G., Chosia M., Scott R., and Lubiński J. Germline 657del5 mutation in the NBS1 gene in breast cancer patients. Int J Cancer 106 (2003) 379-381
11. Buslov K.G., Iyevleva A.G., Chekmariova E.V., Suspitsin E.N., Togo A.V., Kuligina E., Sokolenko A.P., Matsko D.E., Turkevich E.A., Lazareva Y.R., Chagunava O.L., Bit-Sava E.M., Semiglazov V.F., Devilee P., Cornelisse C., Hanson K.P., and Imyanitov E.N. NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia. Int J Cancer 114 (2005) 585-589
12. Sokolenko A.P., Rozanov M.E., Mitiushkina N.V., Sherina N.Y., Iyevleva A.G., Chekmariova E.V., Buslov K.G., Shilov E.S., Togo A.V., Bit-Sava E.M., Voskresenskiy D.A., Chagunava O.L., Devilee P., Cornelisse C., Semiglazov V.F., and Imyanitov E.N. Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia. Fam Cancer 6 (2007) 281-286
13. Leegte B., van der Hout A.H., Deffenbaugh A.M., Bakker M.K., Mulder I.M., ten Berge A., Leenders E.P., Wesseling J., de Hullu J., Hoogerbrugge N., Ligtenberg M.J., Ardern-Jones A., Bancroft E., Salmon A., Barwell J., Eeles R., and Oosterwijk J.C. Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations. J Med Genet 42 (2005) e20
14. Bell D.W., Erban J., Sgroi D.C., and Haber D.A. Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2. Cancer Res 62 (2002) 2741-2743
15. Berchuck A., Heron K.A., Carney M.E., Lancaster J.M., Fraser E.G., Vinson V.L., Deffenbaugh A.M., Miron A., Marks J.R., Futreal P.A., and Frank T.S. Frequency of germline and somatic BRCA1 mutations in ovarian cancer. Clin Cancer Res 4 (1998) 2433-2437
16. Plisiecka-Hałasa J., Dansonka-Mieszkowska A., Rembiszewska A., Bidziński M., Steffen J., and Kupryjańczyk J. Nijmegen breakage syndrome gene (NBS1) alterations and its protein (nibrin) expression in human ovarian tumours. Ann Hum Genet 66 (2002) 353-359
17. Tessitore A., Biordi L., Flati V., Toniato E., Marchetti P., Ricevuto E., Ficorella C., Scotto L., Giannini G., Frati L., Masciocchi C., Tombolini V., Gulino A., and Martinotti S. New mutations and protein variants of NBS1 are identified in cancer cell lines. Genes Chromosomes Cancer 36 (2003) 198-204
18. King T.A., Li W., Brogi E., Yee C.J., Gemignani M.L., Olvera N., Levine D.A., Norton L., Robson M.E., Offit K., Borgen P.I., and Boyd J. Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis. Ann Surg Oncol 14 (2007) 2510-2518
19. Santarosa M., and Ashworth A. Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way. Biochim Biophys Acta 1654 (2004) 105-122
20. Tanzanella C., Antoccia A., Spadoni E., di Masi A., Pecile V., Demori E., Varon R., Marseglia G.L., Tiepolo L., and Maraschio P. Chromosome instability and nibrin protein variants in NBS heterozygotes. Eur J Hum Genet 11 (2003) 297-303
21. Barwell J., Pangon L., Georgiou A., Kesterton I., Langman C., Arden-Jones A., Bancroft E., Salmon A., Locke I., Kote-Jarai Z., Morris J.R., Solomon E., Berg J., Docherty Z., Camplejohn R., Eeles R., and Hodgson S.V. Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibility. Int J Cancer 121 (2007) 1631-1636